![](/img/cover-not-exists.png)
A multicenter, open-label, long-term safety and tolerability study of DFN-02, an intranasal spray of sumatriptan 10 mg plus permeation enhancer DDM, for the acute treatment of episodic migraine
Munjal, Sagar, Brand-Schieber, Elimor, Allenby, Kent, Spierings, Egilius L.H., Cady, Roger K., Rapoport, Alan M.Volume:
18
Language:
english
Journal:
The Journal of Headache and Pain
DOI:
10.1186/s10194-017-0740-3
Date:
December, 2017
File:
PDF, 486 KB
english, 2017